Tissue engineering has brought revolutionary potential to the regenerative repair of damaged tissues, providing innovative solutions to restore function.

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under two years, despite ...

Catalent, Inc., a leading global contract development and manufacturing organization, today highlighted new innovations from its SMARTag® antibody-drug conjugate (ADC) technology platform. The company ...

IND application filed for MP0712, the Company's lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images f ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy, yet their efficacy varies widely across individuals. Emerging evidence ...

T-Knife CEO Thomas Soloway explains how next-generation “supercharged” T-cell aims to overcome the tumor microenvironment’s ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

Researchers used pot experiments to investigate, through measuring plant physiological and biochemical indicators, soil ...

Ensoma, an in vivo hematopoietic stem cell (HSC) engineering company with a mission to advance the future of medicine through one-time therapies, today announced new preclinical data demonstrating ...

Scientists have long wondered why Earth's overall makeup doesn't fully match the mix of materials found in ancient meteorites ...